Source: Annual Congress 2009 - Inflammation and airways
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanak, L. Mastalerz, M. Kaszuba, B. Sokolowska, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland). Characteristic pattern of lipoxygenase products in exhaled breath condensates from patients with Churge-Strauss syndrome. Eur Respir J 2009; 34: Suppl. 53, 2119

Member's Comments

No comment yet.

Related content which might interest you: Eicosanoids in exhaled breath condensate of children with primary ciliary dyskinesia Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001 Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Exhaled breath condensate eicosanoids as markers of asthma severity Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Inflammatory markers in exhaled breath condensate differ between pre-school children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 TNF-α in exhaled breath condensate and in serum of scleroderma patients Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Nitric oxide metabolites in exhaled breath condensate of children with primary ciliary dyskinesia Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001 Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 680s Year: 2004 The differences in the arachidonate metabolites in breath condensates from patients with Churg-Strauss syndrome Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Correlation of FENO with nitrites and nitrates in exhaled breath condensate in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Effect of exercise on the levels of cyclooxygenase products in exhaled breath condensate in leading sportsmen Source: Eur Respir J 2002; 20: Suppl. 38, 411s Year: 2002 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease? Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Supplementation with antioxidants in Down syndrome: the effects on exhaled breath condensate (EBC) and serum Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 Cytokines in exhaled breath condensate of patients with asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008